Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Correction to: Tcf‑1 protects anti‑tumor TCR‑engineered CD8+ T‑cells from GzmB mediated self‑destruction ; day:6 ; month:6 ; year:2022 ; pages:1
Cancer immunology immunotherapy ; (6.6.2022), 1
- Creator
-
Zangari, Brendan
Tsuji, Takemasa
Matsuzaki, Junko
Mohammadpour, Hemn
Eppolito, Cheryl
Battaglia, Sebastiano
Ito, Fumito
Chodon, Thinle
Koya, Richard
Robert McGray, A. J.
Odunsi, Kunle
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-022-03233-1
- URN
-
urn:nbn:de:101:1-2022080323082923173934
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zangari, Brendan
- Tsuji, Takemasa
- Matsuzaki, Junko
- Mohammadpour, Hemn
- Eppolito, Cheryl
- Battaglia, Sebastiano
- Ito, Fumito
- Chodon, Thinle
- Koya, Richard
- Robert McGray, A. J.
- Odunsi, Kunle
- SpringerLink (Online service)
Other Objects (12)
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Memory IgM protects endogenous insulin from autoimmune destruction
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
TcR
Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature T-cells
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
Ko-Tests: TCR
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Memory IgM protects endogenous insulin from autoimmune destruction
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
TcR
Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature T-cells
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma
Ko-Tests: TCR
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destruction
TCR-repertoire and homeostasis of Foxp3* regulatory T-cells
Development of a novel TCR avidity assay for human CD8+ T-cells
Deciphering TCR signaling in metabolically activated T-cells in NASH and liver cancer development
Enhanced clinical-scale manufacturing of TCR transduced T-cells using closed culture system modules
Memory IgM protects endogenous insulin from autoimmune destruction
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
TcR
Dynamics of proximal signaling events after TCR/CD8-mediated induction of proliferation or apoptosis in mature T-cells
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma